Chia Tai Tianqing Pharmaceutical - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsChia Tai Tianqing Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Fosaprepitant dimeglumine	Fosaprepitant dimeglumine	2021-03-03		—
Fulvestrant	Fulvestrant	2020-02-07	2034	Breast neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

castration-resistant prostatic neoplasms

,

pharmacokinetics

,

,

non-hodgkin lymphoma

,

endometrioid carcinoma

,

peritoneal neoplasms

,

hereditary breast and ovarian cancer syndrome

,

malignant mesothelioma

,

,

pharmacological phenomena

,

digestive system neoplasms

,

urinary bladder neoplasms

,

neuroendocrine tumors

,

islet cell adenoma

,

urogenital neoplasms

,

female genital neoplasms

,

ovarian neoplasms

,

endometrial neoplasms

,

non-small-cell lung carcinoma

,

prostatic neoplasms

,

ovarian epithelial carcinoma

,

uterine cervical neoplasms

,

colorectal neoplasms

,

squamous cell carcinoma of head and neck

,

,

fallopian tube neoplasms

,

,

pancreatic neoplasms

,

small cell lung carcinoma

,

ductal carcinoma

,

breast diseases

,

stomach neoplasms

,

uterine neoplasms

,

,

brain neoplasms

,

hereditary sensory and autonomic neuropathies

,

carcinoma in situ

,

head and neck neoplasms

,

neoplasms by site

,

urologic neoplasms

,

serous cystadenocarcinoma

,

,

circulating neoplastic cells

,

intraductal carcinoma noninfiltrating

,

,

,

transitional cell carcinoma

,

squamous cell carcinoma

,

,

,

biliary tract neoplasms

,

adenocarcinoma of lung

,

,

,

sex cord-gonadal stromal tumors

,

endometrial stromal sarcoma

,

,

,

pulmonary arterial hypertension

,

familial primary pulmonary hypertension

,

systemic lupus erythematosus

,

precocious puberty

,

polyostotic fibrous dysplasia

,

,

mullerian mixed tumor

,

inborn genetic diseases

,

,

molecular targeted therapy

,

large b-cell lymphoma diffuse

,

salivary gland neoplasms

,

,

myxoid liposarcoma

,

esophageal squamous cell carcinoma

,

squamous cell neoplasms

,

,

,

male breast neoplasms

,

invasive hydatidiform mole

,

disease progression

,

lobular carcinoma

,

ductal carcinoma breast

,

neoadjuvant therapy

,

progression-free survival

,

breast neoplasms

,

,

triple negative breast neoplasms

,

neoplasm metastasis

,

multiple endocrine neoplasia type 1

,

eye abnormalities

Mycophenolate sodium

hyperlipoproteinemia type i

healthy volunteers/patients

,

atopic dermatitis

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

juvenile arthritis

,

breast neoplasms

,

triple negative breast neoplasms

pharmacokinetics

pancreatic ductal carcinoma

,

,

pancreatic neoplasms

,

non-small-cell lung carcinoma

,

Efbemalenograstim alfa

non-small-cell lung carcinoma

,

,

febrile neutropenia

,

colorectal neoplasms

,

pancreatic neoplasms

,

ovarian neoplasms

,

uterine cervical neoplasms

,

,

breast neoplasms

,

Aglatimagene besadenovec

prostatic neoplasms

,

pancreatic neoplasms

,

,

head and neck neoplasms

ovarian neoplasms

,

,

neoplasm metastasis

,

kidney neoplasms

,

,

myeloid leukemia acute

,

hematologic diseases

,

myeloid leukemia

,

myelomonocytic leukemia juvenile

,

,

bone marrow diseases

,

,

colonic neoplasms

,

rectal neoplasms

,

essential thrombocythemia

,

polycythemia vera

,

primary myelofibrosis

,

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

alveolar soft part sarcoma

,

,

,

non-small-cell lung carcinoma

,

triple negative breast neoplasms

,

colorectal neoplasms

,

,

breast neoplasms

,

renal cell carcinoma

,

pancreatic neoplasms

,

hepatocellular carcinoma

,

,

liver neoplasms

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

,

esophageal squamous cell carcinoma

,

squamous cell neoplasms

,

pancreatic ductal carcinoma

,

myelodysplastic syndromes

,

myelomonocytic leukemia chronic

,

ovarian epithelial carcinoma

,

gastrointestinal stromal tumors

,

,

,

small cell lung carcinoma

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

prostatic neoplasms

,

large b-cell lymphoma diffuse

,

neuroendocrine tumors

,

urologic neoplasms

,

thyroid neoplasms

,

esophageal neoplasms

,

uterine cervical neoplasms

,

cholangiocarcinoma

,

unknown primary neoplasms

,

adenocarcinoma of lung

,

clear cell adenocarcinoma

,

,

,

uveal neoplasms

,

adenomyoepithelioma

,

,

hematologic neoplasms

,

castration-resistant prostatic neoplasms

,

b-cell lymphoma

,

head and neck neoplasms

,

non-hodgkin lymphoma

,

neuroendocrine carcinoma

,

endometrial neoplasms

,

anaplastic thyroid carcinoma

,

,

,

hodgkin disease

,

myelodysplastic syndromes

,

,

chemotherapy-induced febrile neutropenia

,

healthy volunteers/patients

1

2

3

4

5

6

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use